Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Convenient Way to Screen Hydrogel Stiffness for Stem Cell Applications

Published: Tuesday, August 28, 2012
Last Updated: Tuesday, August 28, 2012
Bookmark and Share
BioTime, Inc. announce the debut of their new Glycosan-branded hydrogel kit for screening the stiffness requirements for growing 3D cell cultures.

Research has shown that in addition to induction factors, the rigidity of the substrate on which cells are grown has a significant influence in the lineage specificity of the cell. By mimicking the cell’s in-vivo environment on a petri dish, the cell has a greater affinity to differentiate into specific cell lines.

glycosan.gifThe HyStem-C Stiffness Sampler Trio Kit contains hyaluronan-based, synthetic extracellular matrices that can conveniently screen for the perfect in-vitro environment for stem cells to proliferate.  The kit contains three hydrogels of defined stiffness to take the guesswork out of choosing the right rigidity.  Like its predecessors, the gels are biocompatible, customizable, and allows for attachment of multiple cell types. The hydrogel is easily prepared by mixing the gel and water (both included in the kit) together. Then the cells are either plated on top or encapsulated in the gel. Current applications include vascular morphogenesis, neurogenesis, and other soft tissue cell cultures. For more information, please visit Glycosan’s website at www.glycosan.com.

BioTime, Inc. is a biotechnology company focused on regenerative medicine. The company develops and markets research products in the field of stem cells and regenerative medicine through its wholly owned subsidiary ReCyte Therapeutics, Inc. The company engages in two areas of biomedical research and product development. Its focus is in the field of regenerative medicine; specifically human embryonic stem cell and induced pluripotent stem cell technology. BioTime was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Alameda, CA.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OncoCyte and Abcodia to Collaborate on Breast Cancer Diagnostic Development
PanC-Dx™ markers to be validated using pre-diagnosis patient serum samples exclusively provided by Abcodia.
Tuesday, September 16, 2014
BioTime Completes Merger of XenneX, Inc. into LifeMap Sciences, Inc.
LifeMap Sciences now holds the exclusive, worldwide licenses to market GeneCards(R) and PanDaTox from Yeda Research and Development Company Ltd.
Monday, May 21, 2012
BioTime to Produce Stem Cells for Research in Muscle Disorders
The company announced that it has elected to market progenitors of muscle stem cells bearing hereditary diseases and will produce the products from five human embryonic stem (hES) cell lines from Reproductive Genetics Institute (RGI).
Tuesday, January 03, 2012
BioTime Announces Appointment of Chief Financial Officer
Peter Garcia will lead the accounting, finance and investor relations functions of the Company, reporting directly to Michael D. West, Ph.D., President and CEO.
Monday, October 10, 2011
BioTime and Embryome Sciences Launch Embryome.com and the International Embryome Initiative
The international collaboration with scientists around the world will create the first systematic map of all the cell types derived from human embryonic stem cells.
Monday, June 30, 2008
Scientific News
Crucial for Stem Cell Survival Protein Identified Using Editing Tool CRISPR
A team of University of Wisconsin-Madison engineers has identified a protein that is integral to the survival and self-renewal processes of human pluripotent stem cells (hPSC).
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!